Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Asset Utilization Ratio (2016 - 2025)

Plus Therapeutics has reported Asset Utilization Ratio over the past 13 years, most recently at 0.3 for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 65.19% to 0.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.3 through Dec 2025, down 65.19% year-over-year, with the annual reading at 0.45 for FY2025, 29.74% down from the prior year.
  • Asset Utilization Ratio was 0.3 for Q4 2025 at Plus Therapeutics, down from 0.36 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.09 in Q1 2024 and troughed at 0.01 in Q4 2022.
  • The 4-year median for Asset Utilization Ratio is 0.42 (2025), against an average of 0.43.
  • The largest YoY upside for Asset Utilization Ratio was 7630.43% in 2023 against a maximum downside of 72.14% in 2023.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then skyrocketed by 7630.43% to 0.66 in 2023, then grew by 30.0% to 0.86 in 2024, then plummeted by 65.19% to 0.3 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Asset Utilization Ratio are 0.3 (Q4 2025), 0.36 (Q3 2025), and 0.47 (Q2 2025).